TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Asia Pacific Tranexamic Acid  Market Research Report 2024-2030

Asia Pacific Tranexamic Acid Market Research Report 2024-2030

  • Category:Chemicals and Materials
  • Published on : 24 October 2024
  • Pages :205
  • Formats:
  • Report Code:SMR-8015609
OfferClick for best price

Best Price: $2360

Pacific Tranexamic Acid Market Size, Share 2024


Market size in 2024 US$ 89.4 million
Forecast Market size by 2030 US$ 116.2 million
Growth Rate CAGR of 4.5% Number of Pages 205 Pages

The Asia Pacific Liquid Runway Deicer market size was valued at US$ 89.4 million in 2024 and is projected to reach US$ 116.2 million by 2030, at a CAGR of 4.5% during the forecast period 2024-2030.

Liquid runway deicers are chemical formulations used to prevent or remove ice and snow accumulation on airport runways, taxiways, and aprons, ensuring safe aircraft operations in cold weather conditions.

The Asia Pacific liquid runway deicer market is experiencing moderate growth, driven by expanding air travel and increasing focus on aviation safety. China accounts for 35% of the market, followed by Japan at 25% and South Korea at 20%. In 2023, potassium acetate-based deicers dominated with a 60% market share, followed by propylene glycol-based products at 30%. The market saw an 8% increase in demand for environmentally friendly formulations with lower corrosion potential. Key players include Clariant AG (Switzerland) and Cryotech Deicing Technology (USA), collectively holding a 45% market share in the region. The industry is investing in advanced application technologies, with a 15% increase in adoption of precision spraying systems in 2023. Challenges include environmental concerns and regulatory pressures, leading to a 10% focus on developing bio-based deicer alternatives. The trend towards preventive deicing has driven a 12% growth in demand for anti-icing liquids. The market is benefiting from the expansion of airport infrastructure in emerging economies, with a 20% increase in new airport construction projects incorporating modern deicing facilities.

Report Includes

This report is an essential reference for who looks for detailed information on Asia Pacific Tranexamic Acid . The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Tranexamic Acid , including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.

This report aims to provide a comprehensive presentation of the Asia Pacific Tranexamic Acid , with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tranexamic Acid . This report contains market size and forecasts of Tranexamic Acid in Asia Pacific, including the following market information:

We surveyed the Tranexamic Acid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

by Country

•    China

•    India

•    Japan

•    South Korea

•    Australia

•    Thailand

•    Indonesia

by Products type:

•    USP25

•    BP2000

•    Other

by Application:

•    Trauma

•    Craniocerebral Trauma

•    Menorrhagia

•    Postpartum Hemorrhage

•    Surgery

•    Other Treatment

•    Whitening Cosmetics

key players include: (At least 8-10 companies included)

•    CSL Limited

•    Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

•    JK Sucralose Inc.

•    Yunnan Baiyao Group Co., Ltd.

•    OlainFarm

•    Hisun Pharmaceuticals

•    Pfizer Asia Pacific Pte. Ltd.

•    Wanbang Biopharmaceuticals

•    Sun Pharmaceutical Industries Ltd.

•    Torrent Pharmaceuticals Ltd.

Including or excluding key companies relevant to your analysis.

Competitor Analysis

The report also provides analysis of leading market participants including:

•    Key companies Tranexamic Acid revenues in Asia Pacific market, 2019-2024 (Estimated), ($ millions)

•    Key companies Tranexamic Acid revenues share in Asia Pacific market, 2023 (%)

•    Key companies Tranexamic Acid sales in Asia Pacific market, 2019-2024 (Estimated),

•    Key companies Tranexamic Acid sales share in Asia Pacific market, 2023 (%)

Key Points of this Report:

•    The depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis

•    The report covers Asia Pacific and country-wise market of Tranexamic Acid

•    It describes present situation, historical background and future forecast

•    Comprehensive data showing Tranexamic Acid capacities, production, consumption, trade statistics, and prices in the recent years are provided

•    The report indicates a wealth of information on Tranexamic Acid manufacturers

•    Tranexamic Acid forecast for next five years, including market volumes and prices is also provided

•    Raw Material Supply and Downstream Consumer Information is also included

•    Any other user's requirements which is feasible for us

Reasons to Purchase this Report:

•    Analyzing the outlook of the market with the recent trends and SWOT analysis

•    Market dynamics scenario, along with growth opportunities of the market in the years to come

•    Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects

•    Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.

•    Market value (USD Million) and volume (Units Million) data for each segment and sub-segment

•    Distribution Channel sales Analysis by Value

•    Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years

•    Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

•    1-year analyst support, along with the data support in excel format.

Report Attributes Report Details
Report Title Asia Pacific Tranexamic Acid Market Research Report 2024-2030
Market size in 2024 US$ 89.4 million
Forecast Market size by 2030 US$ 116.2 million
Growth Rate CAGR of 4.5%
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 205 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Market Overview    



1.1 Product Overview and Scope of Tranexamic Acid  



1.2 Segment by Type    



1.2.1 Asia Pacific Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030    

1.2.2 USP25    

1.2.3 BP2000

1.2.4 Other


1.3 Segment by Application  



1.3.1 Asia Pacific Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030    

1.3.2    Trauma

1.3.3    Craniocerebral Trauma

1.3.4    Menorrhagia

1.3.5    Postpartum Hemorrhage

1.3.6    Surgery

1.3.7    Other Treatment

1.3.8    Whitening Cosmetics

1.4 Asia Pacific Market Growth Prospects    

1.4.1 Asia Pacific Revenue Estimates and Forecasts (2019-2030)    

1.4.2 Asia Pacific Production Estimates and Forecasts (2019-2030)  



2 Asia Pacific Growth Trends    



2.1 Industry Trends    

2.1.1 SWOT Analysis    

2.1.2 PESTEL Analysis    

2.1.3 Porter’s Five Forces Analysis    

2.2 Potential Market and Growth Potential Analysis    



3 Market Competition by Manufacturers  



3.1 Asia Pacific Production by Manufacturers (2019-2023)    

3.2 Asia Pacific Revenue Market Share by Manufacturers (2019-2023)    

3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)    

3.4 Asia Pacific Average Price by Manufacturers (2019-2023)    

3.5 Manufacturers Production Sites, Area Served, Product Type    

3.6 Market Competitive Situation and Trends    

3.6.1 Market Concentration Rate    

3.6.2 Asia Pacific 5 and 10 Largest Players Market Share by Revenue    

3.6.3 Mergers & Acquisitions, Expansion  



4 Production by Region



4.1 Asia Pacific Production    

4.1.1 Asia Pacific Production YoY Growth Rate (2019-2023)    

4.1.2 Asia Pacific Production, Revenue, Price and Gross Margin (2019-2024)  



5 Consumption by Region  



5.1 Asia Pacific    

5.1.1 Asia Pacific Consumption by Country    

5.1.2 Asia Pacific Sales, Consumption, Export, Import (2019-2023)    

5.1.1 China    

5.2.2 India

5.3.3 Japan

5.4.4 South Korea

5.5.5 Australia

5.6.6 Thailand

5.7.7 Indonesia


6 Segment by Type   



6.1 Asia Pacific Production Market Share by Type (2019-2024)    

6.2 Asia Pacific Revenue Market Share by Type (2019-2024)    

6.3 Asia Pacific Price by Type (2019-2024) 



7 Segment by Application  



7.1 Asia Pacific Production Market Share by Application (2019-2024)    

7.2 Asia Pacific Revenue Market Share by Application (2019-2024)    

7.3 Asia Pacific Price by Application (2019-2024)  



8 Key Companies Profiled    



8.1 CSL Limited    

8.1.1 CSL Limited Corporation Information    

8.1.2 CSL Limited Product Portfolio    

8.1.3 CSL Limited Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.1.4 CSL Limited Main Business and Markets Served    

8.1.5 CSL Limited Recent Developments/Updates    

8.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.    

8.2.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information    

8.2.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Product Portfolio    

8.2.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.2.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Main Business and Markets Served    

8.2.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates    

8.3 JK Sucralose Inc.    

8.3.1 JK Sucralose Inc. Corporation Information    

8.3.2 JK Sucralose Inc. Product Portfolio    

8.3.3 JK Sucralose Inc. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.3.4 JK Sucralose Inc. Main Business and Markets Served    

8.3.5 JK Sucralose Inc. Recent Developments/Updates    

8.4 Yunnan Baiyao Group Co., Ltd.    

8.4.1 Yunnan Baiyao Group Co., Ltd. Corporation Information    

8.4.2 Yunnan Baiyao Group Co., Ltd. Product Portfolio    

8.4.3 Yunnan Baiyao Group Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.4.4 Yunnan Baiyao Group Co., Ltd. Main Business and Markets Served    

8.4.5 Yunnan Baiyao Group Co., Ltd. Recent Developments/Updates    

8.5 OlainFarm    

8.5.1 OlainFarm Corporation Information    

8.5.2 OlainFarm Product Portfolio    

8.5.3 OlainFarm Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.5.4 OlainFarm Main Business and Markets Served    

8.5.5 OlainFarm Recent Developments/Updates    

8.6 Hisun Pharmaceuticals    

8.6.1 Hisun Pharmaceuticals Corporation Information    

8.6.2 Hisun Pharmaceuticals Product Portfolio    

8.6.3 Hisun Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.6.4 Hisun Pharmaceuticals Main Business and Markets Served    

8.6.5 Hisun Pharmaceuticals Recent Developments/Updates    

8.7 Pfizer Asia Pacific Pte. Ltd.    

8.7.1 Pfizer Asia Pacific Pte. Ltd. Corporation Information    

8.7.2 Pfizer Asia Pacific Pte. Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.7.3 Pfizer Asia Pacific Pte. Ltd. Main Business and Markets Served    

8.7.4 Pfizer Asia Pacific Pte. Ltd. Recent Developments/Updates    

8.8 Wanbang Biopharmaceuticals    

8.8.1 Wanbang Biopharmaceuticals Corporation Information    

8.8.2 Wanbang Biopharmaceuticals Product Portfolio    

8.8.3 Wanbang Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.8.4 Wanbang Biopharmaceuticals Main Business and Markets Served    

8.8.5 Wanbang Biopharmaceuticals Recent Developments/Updates    

8.9 Sun Pharmaceutical Industries Ltd.    

8.9.1 Sun Pharmaceutical Industries Ltd. Corporation Information    

8.9.2 Sun Pharmaceutical Industries Ltd. Product Portfolio    

8.9.3 Sun Pharmaceutical Industries Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.9.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served    

8.9.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates    

8.10 Torrent Pharmaceuticals Ltd.    

8.10.1 Torrent Pharmaceuticals Ltd. Corporation Information    

8.10.2 Torrent Pharmaceuticals Ltd. Product Portfolio    

8.10.3 Torrent Pharmaceuticals Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.10.4 Torrent Pharmaceuticals Ltd. Main Business and Markets Served    

8.10.5 Torrent Pharmaceuticals Ltd. Recent Developments/Updates    


9 Manufacturing Cost Analysis    



9.1 Key Raw Materials Analysis    

9.1.1 Key Raw Materials    

9.1.2 Key Suppliers of Raw Materials    

9.2 Proportion of Manufacturing Cost Structure    

9.3 Manufacturing Process Analysis of Tranexamic Acid     

9.4 Industrial Chain Analysis    



10 Marketing Channel, Distributors and Customers  



 10.1 Marketing Channel    

10.2 Distributors List    

10.3 Customers    



11 Market Dynamics



11.1 Industry Trends    

11.2 Market Drivers    

11.3 Market Challenges    

11.4 Market Restraints    



12 Production and Supply Forecast



12.1 Asia Pacific Production, Revenue Forecast (2024-2030)    



13 Consumption and Demand Forecast  



 13.1 Asia Pacific Forecasted Consumption of by Country    



14 Forecast by Type and by Application  



14.1 Asia Pacific Production, Revenue and Price Forecast by Type (2024-2030)    

14.1.1 Asia Pacific Forecasted Production of by Type (2024-2030)    

14.1.2 Asia Pacific Forecasted Revenue of by Type (2024-2030)    

14.1.3 Asia Pacific Forecasted Price of by Type (2024-2030)    

14.2 Asia Pacific Production, Revenue and Price Forecast by Application (2024-2030)    

14.2.1 Asia Pacific Forecasted Production of by Application (2024-2030)    

14.2.2 Asia Pacific Forecasted Revenue of by Application (2024-2030)    

14.2.3 Asia Pacific Forecasted Price of by Application (2024-2030)  



15 Research Findings and Conclusion   



16 Methodology and Data Source    



16.1 Methodology/Research Approach    

16.1.1 Research Programs/Design    

16.1.2 Market Size Estimation    

16.1.3 Market Breakdown and Data Triangulation    

16.2 Data Source    

16.2.1 Secondary Sources    

16.2.2 Primary Sources    

16.3 Author List    

16.4 Disclaimer    



17 Appendix    



17.1 Note    

17.2 Examples of Clients    

LIST OF TABLES & FIGURES



REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount